Inhaled nitric oxide and vasoconstrictors in acute respiratory distress syndrome

American Journal of Respiratory and Critical Care Medicine

Volumn 160, Issue 2, 1999, Pages 473-479

  Papazian, Laurent ^a,b   Roch, Antoine ^a,b   Bregeon, Fabienne ^a,b   Thirion, Xavier ^a,b   Gaillat, Françoise ^a,b   Saux, Pierre ^a,b   Fulachier, Vincent ^a,b   Jammes, Yves ^a,b   Auffray, Jean Pierre ^a,b  

^a HÔPITAL SAINTE MARGUERITE   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALMITRINE DIMESILATE; NITRIC OXIDE; NORADRENALIN; VASOCONSTRICTOR AGENT;

ADULT; AGED; ARTICLE; BLOOD OXYGENATION; CLINICAL ARTICLE; FEMALE; HEMODYNAMICS; HUMAN; MALE; OXYGEN TENSION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESPIRATORY DISTRESS SYNDROME; STATISTICAL ANALYSIS;

EID: 0032798016     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.160.2.9809110     Document Type: Article

References (35)

1. 1. Milberg, J. A., D. R. Davis, K. P., Steinberg, and L. D. Hudson. 1995. Improved survival of patients with acute respiratory distress syndrome: 1983-1993. J.A.M.A. 273:306-309.
2. 2. Lewandowski, K., J. Metz, C. Deutschmann, H. Preib, R. Kuhlen, A. Artigas, and K. J. Falke. 1995. Incidence, severity, and mortality of acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 151:1121-1125.
3. 3. Zapol, W. M., and M. T. Snider. 1977. Pulmonary hypertension in severe acute respiratory failure. N. Engl. J. Med. 296:476-480.
4. 4. Marshall, B. E., C. W. Hanson, F. Frasch, and C. Marshall. 1994. Role of hypoxic pulmonary vasoconstriction in pulmonary gas exchange and blood flow distribution: 2. Pathophysiology. Intensive Care Med. 22: 379-389.
5. 5. Papazian, L., F. Brégeon, F. Gaillat, E. Kaphan, X. Thirion, P. Saux, M. Badier, R. Grégoire, F. Gouin, Y. Jammes, and J. P. Auffray. 1998. Does norepinephrine modify the effects of inhaled nitric oxide on septic patients with acute respiratory distress syndrome? Anesthesiology 89:1089-1098.
6. 6. Bernard, G. R., A. Artigas, K. L. Brigham, J. Carlet, K. Falke, L. D. Hudson, M. Lamy, J. R. Legall, A. Morris, R. Spragg, and the Consensus Committee. 1994. American-European consensus conference on ARDS. Am. J. Respir. Crit. Care Med. 149:818-824.
7. 7. Rossaint, R., K. J. Falke, F. Lopez, K. Slama, U. Pison, and W. M. Zapol. 1993. Inhaled nitric oxide for the adult respiratory distress syndrome. N. Engl. J. Med. 328:399-405.
8. 8. Bigatello, L. M., W. E. Hurford, R. M. Kacmarek, J. D. Roberts, and W. M. Zapol. 1994. Prolonged inhalation of low concentrations of nitric oxide in patients with severe adult respiratory distress syndrome. Anesthesiology 80:761-770.
9. 9. Puybasset, L., J. J. Rouby, E. Mourgeon, P. Cluzel, Z. Souhil, J. D. Law-Koune, T. Stewart, C. Devilliers, Q. Lu, S. Roche, P. Kalfon, E. Vicaut, and P. Viars. 1995. Factors influencing cardiopulmonary effects of inhaled nitric oxide in acute respiratory failure. Am. J. Respir. Crit. Care Med. 152:318-328.
10. 10. Frostell, C. G., H. Blomqvist, G. Hedenstierna, J. Lundberg, and W. M. Zapol. 1993. Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation. Anesthesiology 78:427-435.
11. 11. Krafft, P., P. Fridrich, R. D. Fitzgerald, D. Koe, and H. Steltzer. 1996. Effectiveness of nitric oxide inhalation in septic ARDS. Chest 109: 486-493.
12. 12. Rossaint, R., H. Gerlach, H. Schmidt-Ruhnke, D. Pappert, K. Lewandowski, W. Steudel, and K. Falke. 1995. Efficacy of inhaled nitric oxide in patients with severe ARDS. Chest 107:1107-1115.
13. 2 alpha with and without inhaled nitric oxide in dogs. J. Appl. Physiol. 84:1350-1358.
14. 14. Putensen, C., J. Rasanen, and J. B. Downs. 1994. Effect of endogenous and inhaled nitric oxide on the ventilation-perfusion relationships in oleic-acid lung injury. Am. J. Respir. Crit. Care Med. 150:330-336.
15. 2α on pulmonary circulation and gas exchange in an ovine ARDS model. Intensive Care Med. 22:656-663.
16. 16. Julou-Schaeffer, G., G. A. Gray, I. Fleming, C. Schott, J. R. Parratt, and J. C. Stoclet. 1990. Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. Am. J. Physiol. 259:H1038-H1043.
17. 17. Thiemermann, C., C. Szabo, J. A. Mitchell, and J. R. Vane. 1993. Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide. Proc. Natl. Acad. Sci. U.S.A. 90:267-271.
18. 18. Mourgeon, E., L. Puybasset, J. D. Law-Koune, Q. Lu, L. Abdennour, L. Gallart, P. Malassine, G. S. Umamaheswara Rao, P. Cluzel, A. Bennani, P. Coriat, and J. J. Rouby. 1997. Inhaled nitric oxide in acute respiratory distress syndrome with and without septic shock requiring norepinephrine administration: a dose-response study. Crit. Care 1: 25-39.
19. 19. Doering, E. B., C. W. Hanson, D. J. Reily, C. Marshall, and B. E. Marshall. 1997. Improvement in oxygenation by phenylephrine and nitric oxide in patients with adult respiratory distress syndrome. Anesthesiology 87:18-25.
20. 20. Prost, J. F., P. Desché, F. Jardin, and A. Margairaz. 1991. Comparison of the effects of intravenous almitrine and positive end-expiratory pressure on pulmonary gas exchange in adult respiratory distress syndrome. Eur. Respir. J. 4:683-687.
21. 21. Wysocki, M. C. Delclaux, E. Roupie, O. Langeron, N. Liu, B. Herman, F. Lemaire, and L. Brochard. 1994. Additive effect on gas exchange of inhaled nitric oxide and intravenous almitrine bismesylate in the adult respiratory distress syndrome. Intensive Care Med. 20:254-259.
22. 22. Lu, Q., E. Mourgeon, J. D. Law-Koune, S. Roche, C. Vezinet, L. Abdennour, E. Vicaut, L. Puybasset, M. Diaby, P. Coriat, and J. J. Rouby. 1995. Dose-response of inhaled NO with and without intravenous almitrine in adult respiratory distress syndrome. Anesthesiology 83: 929-943.
23. 23. Dreyfuss, D., K. Djedaini, J. J. Lanore, L. Mier, R. Foidevaux, and F. Coste. 1992. Comparative study of the effects of almitrine bismesylate and lateral position during unilateral bacterial pneumonia with severe hypoxemia. Am. Rev. Respir. Dis. 146:295-299.
24. 24. Jolliet, P., P. Bulpa, M. Ritz, B. Ricou, J. Lopez, and J. C. Chevrolet. 1997. Additive beneficial effects of the prone position, nitric oxide, and almitrine bismesylate on gas exchange and oxygen transport in the acute respiratory distress syndrome. Crit. Care Med. 25:786-794.
25. 25. Gallart, L., Q. Lu, L. Puybasset, S. Umamaheswara Rao, P. Coriat, J. J. Rouby, and the NO Almitrine Study Group. 1998. Intravenous almitrine combined with inhaled nitric oxide for acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 158:1770-1777.
26. 26. Reyes, A., J. Roca, R. Rodriguez-Roisin, A. Torres, P. Ussetti, and P. D. Wagner. 1988. Effect of almitrine on ventilation-perfusion distribution in adult respiratory distress syndrome. Am. Rev. Respir. Dis. 137: 1062-1067.
27. 27. Leeman, M., M. Delcroix, J. L. Vachiéry, C. Mélot, and R. Naeije. 1992. Almitrine and doxapram in experimental lung injury. Am. Rev Respir. Dis. 145:1042-1046.
28. 28. Payen, D., C. Gatecel, and P. Plaisance. 1993. Almitrine effect on almitrine oxide inhalation in adult respiratory distress syndrome. Lancet 341:1664.
29. 29. Falus, F., J. Berget, and V. Hampl. 1991. Almitrine in low dose potentiates vasoconstrictor responses of isolated rat lungs to moderate hypoxia. Eur. Respir. J. 4:688-693.
30. 30. Nakanishi, S., T. Hiramoto, N. Ahmed, and Y. Nishimoto. 1988. Almitrine enhances in low dose the reactivity of pulmonary vessels to hypoxia. Respir. Physiol. 74:139-150.
31. 31. Romaldini, H., R. Rodriguez-Roisin, P. D. Wagner, and J. B. West. 1983. Enhancement of hypoxic pulmonary vasoconstriction by almitrine in the dog. Am. Rev. Respir. Dis. 128:288-293.
32. 32. Gottschall, E. B., S. Fernyak, G. Wuertemberger, and N. F. Voelkel. 1992. Almitrine mimics hypoxic vasoconstriction in isolated rat lungs. Am. J. Physiol. 263:H383-H391.
33. 33. Russell, P. C., C. J. Emery, J. Nicholl, G. R. Barer, and P. Howard. 1992. Interactions between hypoxic and almitrine-induced vasoconstriction in the rat lung. Clin. Sci. 82:265-272.
34. 34. Dellinger, R. P., J. L. Zimmerman, R. W. Taylor, R. C. Straube, D. L. Hauser, G. J. Criner, K. Davis, Jr., T. M. Hiers, and P. Papadakos. 1998. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group. Crit. Care Med. 26:15-23.
35. 35. Papazian, L., F. Bregeon, F. Gaillat, X. Thirion, M. Gainnier, R. Grégoire, P. Saux, F. Gouin, Y. Jammes, and J. P. Auffray. 1998. Respective and combined effects of prone position and inhaled nitric oxide in patients with acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 157:580-585.